Liraglutide
Liraglutide is an injected GLP-1 medicine used for type 2 diabetes and for weight loss. It copies a gut hormone that slows the gut, curbs hunger, and helps the body handle sugar.
Women with PCOS (polycystic ovary syndrome, now also called PMOS) often meet it as a weight drug. Across 11 short trials, liraglutide with metformin had a high chance of more than 1 kilogram of extra weight loss, set against metformin alone.1 Lower insulin resistance can let ovulation return. These trials tracked bleeding as the sign of ovulation, which is a weak measure.
Human pregnancy data for GLP-1 medicines are limited.2
Cited in this entry
- Song E, Fang Y, Li X, Fu W, He H, Gao Z, Tian X, Gao B. Balancing metabolic optimization and reproductive safety in Polycystic Ovary Syndrome: a Bayesian-informed framework for GLP-1 receptor agonists. Frontiers in nutrition. 2026. https://pubmed.ncbi.nlm.nih.gov/42311951/
- Becker AS, Castilhos JP, Shugair SAS, Colombo T, Hentschke MR. GLP-1 Receptor Agonists and Fertility: What Is Known So Far?. JBRA assisted reproduction. 2026. https://pubmed.ncbi.nlm.nih.gov/42441883/
This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.
